Meconio: vehiculo de biomarcadores de exposición a sustancias psicoactivas en gestantes

Sandra Manrrique Lopez; Milena Orjuela Velasco; Sonia Puentes Garcia

doi:10.22490/24629448.377

Vol. 5 No. 7 (2007)

Published 2007-06-15

license

Article of Review (before OJS)

Meconium: Biomarker Vehicle of Expusure to Psychoactive Substances in Pregnant Women

DOI: https://doi.org/10.22490/24629448.377

Sandra Manrrique Lopez Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.

Milena Orjuela Velasco Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.

Sonia Puentes Garcia Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.

PDF (Spanish)

Abstract
References

Children exposed to drugs in a prenatal way are a medical and social problem. A useful way to study this problem is by analyzing biological matrices, such as the meconium, which stores psychoactive substances or their metabolites. To determine its fetal exposure the most common system is the analysis of blood from the umbilical cord, urine from the mother, or urine from the new born. Meconium is inert and it is easily obtainable. It stores psychoactive substances or its metabolites from week 12 of gestation and they are fossilized in it until birth. It can be a very important instrument to investigate fetal exposure to several drugs of abuse. It is necessary to know the degree of fetal exposure to contribute to the prognosis and timely pathology treatment which, due to the lack of clinical relevant manifestations, can be overlooked and require the implementation of tests that use reliable biological matrices.

keywords: cocaine, etanol, fetal growth retardation fetal alcohol syndrome, marijuana, meconium, neonatal abstinence syndrome.

Kaloðlu C, Gürsoy E, Onarlioðlu B. Early maternal changes contributing to the formation of the chorioallantoic and yolk sac placentas in rat: a morphological study. Anat Histol Embryol. 2003;32:200-206.

A. C. Enders A, Carter A. What Can Comparative Studies of Placental Structure Tell Us?—A Review Placenta 2004; 25:S3-S9.

Burton G, Jauniaux E, Charnock-Jones D. Human Early Placental Development: Potential Rolesof the Endometrial Glands. Placenta. 2007;21:S64-S69.

Weissgerber T, Wolfe L. Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands. Appl Physiol Nutr Metab. 2006;31:1-11

Myren M, Mose T, Mathiesen L, Knudsen L. The human placenta-An alternative for studying foetal exposure. Toxicol In Vitro. 2007; 7: [Epub ahead of print].

Ortega J., Carrizo D, Ferris J, Peinador M, Grimalt J. Meconium and neurotoxicans. Revista Española De Pediatría. 2004,60:291-296.

Mur A, García O, López N. Toxicidad de la cocaína en el recién nacido. Detección y prevalencia. An Esp Pediatr 2002;56:241-246

Ostrea E, Knapp D, Tannenbaum L, Ostrea A, Romero A, Salari V, Ager J. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344-348.

Doris J, Meguid V, Thomas M, Blatt S, Eckenrode J. Prenatal cocaine exposure and child welfare outcomes. Child Maltreat. 2006;11:326-337.

Lewis D, Moore C, Leikin J, Koller A. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J Anal Toxicology. 1995;19:148-150.

Kapusta N, Plener P, Schmid R, Thau K, Walter H, Lesch O. Multiple substance use among young males. Pharmacol Biochem Behav. 2007;86:306-311.

Schuetze P, Eiden R, Coles C. Prenatal cocaine and other substance exposure: effects on infant autonomic regulation at 7 months of age. Dev Psychobiol. 2007;49:276-89

Shankaran S, Lester B, Das A, Bauer C, Bada H, Lagasse L, Higgins R. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med. 2007;12:143-50.

Periódico El Tiempo. El Consumo De Alcohol, Marihuana, Cocaína Y Basuco Está ‘Disparado’ En Bogotá. Julio 31 De 2006.

Gauthier T, Manar M, Brown L. Is maternal alcohol use a risk factor for early-onset sepsis in premature newborns? Alcohol. 2004;33:139-145.

Nelson S, Lerner E, Needlman R, Salvator A, Singer L. Cocaine, anemia, and neurodevelopmental outcomes in children: a longitudinal study. J Dev Behav Pediatr. 2004;25:1-9.

Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early development. Early Hum Dev 2001;65:21-37.

Stanwood G, Levitt P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci. 2007;27:152-157.

Tapia J, Ventura P. Manual de neonatología. Edt. Mediterráneo. Santiago de Chile. 2000.

Vigilancia Epidemiológica Del Consumo De SPA En Bogota, Estadísticas, 2001, 2004, 2005, 2006. Secretaria Distrital De Salud.

Velasquez. J. Farmacología y Toxicología Clínica. Ed. Panamericana 2005, 384–392

license

How to Cite

Manrrique Lopez, S., Orjuela Velasco, M., & Puentes Garcia, S. (2007). Meconium: Biomarker Vehicle of Expusure to Psychoactive Substances in Pregnant Women. NOVA Biomedical Sciences Journal, 5(7), 76-83. https://doi.org/10.22490/24629448.377

Download Citation

Almétricas

Metrics

Metrics Loading ...

Declaración de privacidad.

Meconium: Biomarker Vehicle of Expusure to Psychoactive Substances in Pregnant Women

How to Cite